Tonix Pharmaceuticals Holding Corp. (47)

Browse by Contract Category

Contracts

Purchase and Sale Agreement, dated July 26, 2021, between the Company and Southern Research (Filed With SEC on August 9, 2021)
License Agreement, dated April 14, 2021, between the Company and OyaGen, Inc (Filed With SEC on May 10, 2021)
Description of Registrants Securities (Filed With SEC on March 15, 2021)
Employment Agreement, dated February 23, 2021, between the Company and Bradley Saenger (Filed With SEC on February 26, 2021)
Placement Agency Agreement, dated February 8, 2021 between the Company and A.G.P./Alliance Global Partners (Filed With SEC on February 9, 2021)
Second Amendment of Lease and Assignment of Lease (this Amendment) made as of December 6, 2018, by and between 509 Madison Avenue Associates, LP, and Tonix Pharmaceuticals, Inc (Filed With SEC on March 18, 2019)
Registration Rights Agreement, dated May 14, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2021)
Purchase Agreement, dated May 14, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2021)
Purchase and Sale Agreement, dated March 5, 2021, between Tonix Pharmaceuticals Holding Corp. and the Seller named therein (Filed With SEC on March 15, 2021)
Employment Agreement, dated February 23, 2021, between the Company and Jessica Morris (Filed With SEC on February 26, 2021)
Form of Securities Purchase Agreement, dated February 8, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on February 9, 2021)
Form of Investor Agreement, dated February 8, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on February 9, 2021)
Form of Securities Purchase Agreement, dated January 11, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on January 12, 2021)
Placement Agency Agreement, dated January 11, 2021 between the Company and A.G.P./Alliance Global Partners (Filed With SEC on January 12, 2021)
Purchase and Sale Agreement, dated October 14, 2020 (Filed With SEC on November 9, 2020)
Registration Rights Agreement, dated September 3, 2020, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 4, 2020)
Purchase Agreement, dated September 3, 2020, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 4, 2020)
Assignment and Agreement, dated June 11, 2020, between the Company and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on August 10, 2020)
Amended and Restated Exclusive License Agreement, dated June 11, 2020, between the Company and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on August 10, 2020)
Asset Purchase Agreement, dated June 11, 2020, between the Company and Trigemina, Inc (Filed With SEC on August 10, 2020)
Purchase and Sale Agreement, dated July 1, 2020 (Filed With SEC on August 10, 2020)
Form of Securities Purchase Agreement, dated July 13, 2020, by and between the Company and the Purchasers thereunder (Filed With SEC on July 14, 2020)
Placement Agency Agreement, dated July 13, 2020 between the Company and A.G.P./Alliance Global Partners (Filed With SEC on July 14, 2020)
License Agreement, dated May 5, 2020, between Tonix Pharmaceuticals (Canada) Inc. and The Governors of the University of Alberta (Filed With SEC on May 12, 2020)
Research Service Agreement, May 6, 2020, between Tonix Pharmaceuticals (Canada) Inc. and The Governors of the University of Alberta (Filed With SEC on May 12, 2020)
Research Collaboration Agreement between Tonix Pharmaceutical, Inc. and Southern Research Institute, dated November 7, 2018 (Filed With SEC on March 24, 2020)
Description of Registrants Securities (Filed With SEC on March 24, 2020)
Form of Securities Purchase Agreement, dated February 28, 2020, by and between the Company and the Purchasers thereunder (Filed With SEC on February 28, 2020)
Placement Agency Agreement, dated February 28, 2020 between the Company and A.G.P./Alliance Global Partners (Filed With SEC on February 28, 2020)
Form of Warrant Agency Agreement (Filed With SEC on February 6, 2020)
Form of Warrant (Filed With SEC on February 6, 2020)
Form of Underwriting Agreement (Filed With SEC on February 6, 2020)
Form of Warrant (Filed With SEC on November 15, 2019)
Form of Common Warrant (Filed With SEC on November 15, 2019)
Form of Underwriting Agreement (Filed With SEC on November 14, 2019)
Form of Common Stock Purchase Warrant (Filed With SEC on November 14, 2019)
Form of Warrant (Filed With SEC on November 14, 2019)
Form of Warrant Agency Agreement (Filed With SEC on November 14, 2019)
Form of Warrant Agreement (Filed With SEC on November 14, 2019)
Exclusive License Agreement, dated September 16, 2019, between Tonix Pharmaceuticals Holding Corp. and The Trustees of Columbia University in the City of New York (Filed With SEC on November 8, 2019)
First Amended and Restated Exclusive License Agreement, dated August 19, 2019, between Tonix Pharmaceuticals Holding Corp. and Wayne State University (Filed With SEC on November 8, 2019)
Asset Purchase Agreement, dated August 19, 2019, between Tonix Pharmaceuticals Holding Corp. and TRImaran Pharma, Inc (Filed With SEC on November 8, 2019)
Registration Rights Agreement, dated August 20, 2019, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 23, 2019)
Purchase Agreement, dated August 20, 2019, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 23, 2019)
License Agreement, dated May 20, 2019, between Tonix Pharmaceuticals Holding Corp. and The Trustees of Columbia University in the City of New York (Filed With SEC on August 12, 2019)
Form of Underwriting Agreement (Filed With SEC on July 15, 2019)
Form of Underwriting Agreement (Filed With SEC on July 11, 2019)